- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nephros Inc (NEPH)
The Nephros share price today is 4.270, view NASDAQ NEPH stock exchange data. Track the latest Nephros share price with real-time updates on NEPH stock performance including market cap, day range, 52-week range and dividend yield. Access NEPH charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.000
4.515
52 wk Range
2.663
6.420
NEPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.0004.515
52 wk Range
2.6636.420
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NEPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
6.000
Upside
+40.52%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.000
(+40.52% Upside)
Nephros Inc Earnings Call Summary for Q2/2026
- Nephros reported Q2 2026 record revenue of $6.0M, up 36% YoY; net income surged to $1.2M from $237K; shares rose 5% premarket to $3.77.
- Service revenue nearly tripled, driving growth alongside 67% gross margin boosted by $600K tariff refund; adjusted EBITDA jumped 260% to $1.3M.
- Company beat EPS estimates at $0.01 vs. $0.00 expected but missed revenue forecast slightly at $5.0M vs. $5.05M projected.
- Management emphasized shift to integrated water safety platform with recurring revenue focus; no formal guidance issued for remainder of 2026.
- New PFAS and microplastics filtration products remain early-stage; executives expect meaningful contribution in 2-3 quarters as regulations evolve.
Last Updated: 07-08-2026, 03:50 am
Read Full TranscriptEarnings
Latest Release
06-08-2026
EPS / Forecast
0.11 / --
Revenue / Forecast
6.02M / 5.05M
Compare NEPH to Peers and Sector
Metrics to compare | NEPH | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipNEPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.7x | 42.6x | 12.2x | |
PEG Ratio | 0.80 | 0.52 | 0.03 | |
Price/Book | 3.9x | 1.8x | 1.4x | |
Price / LTM Sales | 2.2x | 1.1x | 1.2x | |
Upside (Analyst Target) | 37.0% | 50.7% | 25.8% | |
Fair Value Upside | Unlock | 21.5% | 7.4% | Unlock |
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Nephros (NEPH) Share Price Today?
The Nephros share price today is 4.270.
What is the current Nephros (NEPH) share price and day range?
As of 12-08-2026, the Nephros share price is 4.270, with a previous close of 4.380. The share price has ranged from 4.000 to 4.515 today, while the 52-week range spans from 2.663 to 6.420.
What Is the Nephros Market Cap?
As of today, Nephros market cap is 46.360M.
What Is the Nephros (NEPH) Share Price Target?
The average 12-month share price target for Nephros is 6.000, with a high estimate of 8 and a low estimate of 4. 2 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +40.52% Upside potential.
What Is Nephros's Earnings Per Share (TTM)?
The Nephros EPS (TTM) is 0.160.
When Is the Next Nephros Earnings Date?
Nephros will release its next earnings report on 05-11-2026.
From a Technical Analysis Perspective, Is NEPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Nephros Trade On?
Nephros is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Nephros?
The stock symbol for Nephros is "NEPH."
How Many Times Has Nephros Stock Split?
Nephros has split 2 times.
How Many Employees Does Nephros Have?
Nephros has 36 employees.
What Is the NEPH Premarket Price?
NEPH's last pre-market stock price is 4.470. The pre-market share volume is 460.000, and the stock has changed by 0.090, or 2.050%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.